Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;102(6):1599-1600.
doi: 10.1007/s00277-023-05231-4. Epub 2023 Apr 26.

Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient

Süreyya Yiğit Kaya  1 , Sebnem Bektas  2 , Abdullah Emre Askin  2 , Berrin Balık Aydın  3 , Yaşa Gül Mutlu  4 , Ömür Gökmen Sevindik  4
Affiliations

Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient

Süreyya Yiğit Kaya et al. Ann Hematol. 2023 Jun.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Marks DI, Rowntree C (2017) Management of adults with T-cell lymphoblastic leukemia. Blood 129(9):1134–1142 - DOI - PubMed
    1. Wan CL, Zou JY, Qiao M et al (2021) Venetoclax combined with azacitidine as an effective and safe salvage regimen for relapsed or refractory T-cell acute lymphoblastic leukemia: a case series. Leuk Lymphoma 62(13):3300–3303 - DOI - PubMed
    1. Candoni A, Lazzarotto D, Ferrara F et al (2020) Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study. Am J Hematol 95(12):1466–1472 - DOI - PubMed
    1. Baek DW, Lee JM, Kim J et al (2021) Therapeutic strategies, including allogeneic stem cell transplantation, to overcome relapsed/refractory adult T-cell acute lymphoblastic leukemia. Expert Rev Hematol 14(8):765–775 - DOI - PubMed
    1. Richard-Carpentier G, Jabbour E, Short NJ et al (2020) Clinical experience with venetoclax combined with chemotherapy for relapsed or refractory T-cell acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk 20(4):212–218 - DOI - PubMed

MeSH terms

LinkOut - more resources